ES8700248A3 - Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales. - Google Patents

Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales.

Info

Publication number
ES8700248A3
ES8700248A3 ES539572A ES539572A ES8700248A3 ES 8700248 A3 ES8700248 A3 ES 8700248A3 ES 539572 A ES539572 A ES 539572A ES 539572 A ES539572 A ES 539572A ES 8700248 A3 ES8700248 A3 ES 8700248A3
Authority
ES
Spain
Prior art keywords
solns
ppm
eye
nasal drop
pref
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539572A
Other languages
English (en)
Other versions
ES539572A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to ES539572A priority Critical patent/ES539572A0/es
Publication of ES8700248A3 publication Critical patent/ES8700248A3/es
Publication of ES539572A0 publication Critical patent/ES539572A0/es
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO DE PREPARACION DE COMPOSICIONES FARMACEUTICAS A BASE DE 1,3-BIS (2-CARBOXI-CROMON-5-ILOXI)-PROPAN-2-OL O ALGUNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES, POR EJEMPLO LA SAL DISODICA, EN FORMA DE SOLUCION ACUOSA, TRANSPARENTE Y ESTERIL. COMPRENDE LA DISOLUCION DE LOS INGREDIENTES EN AGUA, PARA PRODUCIR UNA COMPOSICION QUE CONTIENE DE 0,1 A 10% DEL INGREDIENTE ACTIVO, ESTANDO TODOS LOS INGREDIENTES LO MAS EXTENSOS POSIBLE DE IONES METALICOS. CUANDO LA CONCENTRACION DE ESTOS ES MAYOR DE 0,40 PPM SE INCORPORA DE 0,01 A 0,1% EN PESO O VOLUMEN DE UN AGENTE QUELANTE O SECUESTRANTE, FARMACEUTICAMENTE ACEPTABLE, COMO EDTA O ALGUNA DE SUS SALES, Y OPCIONALMENTE INCORPORAR TAMBIEN DE 0,001 A 0,1% DE UN AGENTE CONSERVANTE TAL COMO EL COMPUESTO DE FORMULA (I), EN QUE R ES ALQUILO DE C8H17 HASTA C18H37, O UNA MEZCLA DE ESTOS.
ES539572A 1985-01-15 1985-01-15 Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales. Granted ES539572A0 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES539572A ES539572A0 (es) 1985-01-15 1985-01-15 Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES539572A ES539572A0 (es) 1985-01-15 1985-01-15 Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales.

Publications (2)

Publication Number Publication Date
ES8700248A3 true ES8700248A3 (es) 1986-09-16
ES539572A0 ES539572A0 (es) 1986-09-16

Family

ID=8488538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539572A Granted ES539572A0 (es) 1985-01-15 1985-01-15 Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales.

Country Status (1)

Country Link
ES (1) ES539572A0 (es)

Also Published As

Publication number Publication date
ES539572A0 (es) 1986-09-16

Similar Documents

Publication Publication Date Title
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
EP0634186A3 (en) Respiratory facial mask.
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
NO874908D0 (no) Antimikrobielle proteiner, preparater inneholdende disse og anvendelse derav.
ZA911496B (en) Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
GB8604528D0 (en) Therapeutic agents
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
IL72928A0 (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
GR3005398T3 (es)
EP0632806A1 (en) AMINOCYCLOHEXYLAMIDES FOR ANTI-ARRYMMIC AND ANESTHETIC USE.
IL73189A (en) Process for the pasteurization of concentrates of blood coagulation factors ii,vii,ix and x
EP0488718A3 (en) Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
EP0793434A4 (en) INFLATABLE BLANKET WITH MOLDED OPENINGS
ES8700248A3 (es) Un metodo para preparar una composicion farmaceutica a base de 1,3-bis (2-carboxi-cromon-5-iloxi)-propan-2-ol o una de sus sales.
ZA903334B (en) Cleansing composition
WO1991015466A3 (en) Aminopolycarboxylic acid chelating agents
IT8520250A0 (it) Apparecchio per soffiare il naso alle persone, in particolar modo ai bambini.
ES2120084T3 (es) Vehiculo, especialmente para servicios de salvamento o analogos.
ZA913881B (en) Therapeutic agent
SU1630043A1 (ru) Плазмозамещающий раствор для лечения шока "мафусол"
ZA929176B (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b e)azepine-6,11-dione-11-oximes.
EP0459176A3 (en) Oligophosphates with antiviral activity
Antunes et al. Pattern of susceptibility of Neisseria gonorrhoeae against antimicrobials in Belo Horizonte area.
DE3562997D1 (en) Non-return seal for use in the treatment of wood, process for positioning and closing the seal's bung
DE3760474D1 (en) Process for preparing chlorophenols